| Literature DB >> 35070834 |
Limei Geng1, Yang Yang1.
Abstract
BACKGROUND: Particular factors before and after delivery can cause neurological damage to the fetus or newborn. Rougan Tongdu Tuina combined with point-pressing massage therapy (RTPM) can effectively stimulate the meridians and acupoints, and achieve the therapeutic effects of refreshing, resuscitating, and strengthening the brain and improving cognition. In this study, RTPM was used in the neonatal period, and quality evaluation results of general movements (GMs) were used to monitor the effect of this method on neurodevelopmental outcomes of children.Entities:
Keywords: Tuina; motor development retardation; neurodevelopment; point-pressing
Year: 2021 PMID: 35070834 PMCID: PMC8753475 DOI: 10.21037/tp-21-558
Source DB: PubMed Journal: Transl Pediatr ISSN: 2224-4336
Comparison of baseline characteristics between therapy group and controlled group
| Characteristics | Therapy group (n=51) | Controlled group (n=45) | t/χ2 value | P value |
|---|---|---|---|---|
| Male (n, %) | 28 (54.9) | 29 (64.4) | 0.903 | 0.342 |
| Gestational age (w) | 32.7±1.8 | 33.1±1.7 | 1.118 | 0.268 |
| Birth weight (g) | 1973±148 | 2014±163 | 1.292 | 0.200 |
| Apgar score | 7.3±2.1 | 7.5±2.2 | 0.455 | 0.650 |
| Twins (n, %) | 3 (5.9) | 2 (4.4) | 0.021 | 0.886 |
| GD (n, %) | 30 (58.8) | 34 (75.6) | 3.011 | 0.083 |
| PH (n, %) | 35 (68.6) | 31 (68.9) | 0.001 | 0.978 |
| HP (n, %) | 2 (3.9) | 3 (6.7) | 0.365 | 0.546 |
| FLP (n, %) | 1 (2.0) | 2 (4.4) | 0.012 | 0.912 |
| Kidney disease (n, %) | 2 (3.9) | 1 (2.2) | 0.012 | 0.912 |
| ICS (n, %) | 27 (52.9) | 28 (62.2) | 0.842 | 0.359 |
| ICH (n, %) | 2 (3.9) | 1 (2.2) | 0.012 | 0.912 |
| CNS infection (n, %) | 4 (7.8) | 3 (6.7) | 0.030 | 0.863 |
| NHB (n, %) | 38 (74.5) | 40 (88.9) | 3.245 | 0.072 |
| Intervention start time (d) | 2.0±0.4 | 1.9±0.3 | 1.371 | 0.174 |
| Parity (n, %) | 0.305 | 0.858 | ||
| 1 | 10 (19.6) | 7 (15.6) | ||
| 2 | 35 (68.6) | 33 (73.3) | ||
| ≥3 | 6 (11.8) | 5 (11.1) | ||
| Delivery method (n, %) | 0.423 | 0.810 | ||
| Normal delivery | 16 (31.4) | 15 (33.3) | ||
| Forceps | 3 (5.9) | 4 (8.9) | ||
| Cesarean section | 32 (62.7) | 26 (57.8) |
GD, gestational diabetes; PH, pregnancy hypertension; HP, hyperthyroidism in pregnancy; FLP, fatty liver of pregnancy; ICS, indicated cesarean section; ICH, intracranial hemorrhage; NHB, neonatal hyperbilirubinemia.
Gesell development scales scores of the two groups before and six months after intervention ()
| Groups | Coarse movement | Fine movement | Total motor function |
|---|---|---|---|
| Therapy group (n=51) | 88.0±7.2a* | 88.3±5.6a* | 89.1±5.1a* |
| Controlled group (n=45) | 71.33±5.2a | 70.5±6.1a | 72.3±5.6a |
a, compared with scores before intervention, P<0.05; *, compared with controlled group, P<0.05.
Comparison of the number of cases with abnormal GMs assessment after 20 days of each treatment
| Characteristics | Therapy group (n=51) | Controlled group (n=45) | χ2 value | P value |
|---|---|---|---|---|
| 20 days after the first therapy (n, %) | 37 (72.5) | 42 (93.3) | 7.087 | 0.008 |
| 20 days after the second therapy (n, %) | 12 (23.5) | 35 (77.8) | 28.154 | <0.001 |
| 20 days after the third therapy (n, %) | 3 (5.9) | 17 (37.8) | 14.746 | 0.0001 |
GMs, general movements.
Effectiveness in Therapy group [n (%)]
| Characteristics | Therapy group (n=51) | Controlled group (n=45) | χ2 value | P value |
|---|---|---|---|---|
| Significantly effective (n, %) | 38 (74.5) | 15 (33.3) | ||
| Effective (n, %) | 9 (17.6) | 19 (42.2) | 16.509 | 0.0003 |
| Invalid (n, %) | 4 (7.8) | 11 (24.4) | ||
| Total effective rate (n, %) | 47 (92.2) | 34 (75.6) | 4.998 | 0.025 |